Contact us

CORPORATE PRESENTATIONS

01-12-2021 Bio-Gene CEO, Richard Jagger Presents at Stockheads V-Con
08-11-2021 Bio-Gene CEO, Richard Jagger Interview with Ticknews
28-10-2021 Bio-Gene CEO Investor Briefing
31-08-2021 Bio-Gene Executive Director R&D, Peter May presents at 14th Mosquito Control Association of Australia Symposium
31-08-2021 Bio-Gene Presentation Slides - 14th Mosquito Control Association of Australia Symposium
12-08-2021 Bio-Gene Investment Summary
28-07-2021 Bio-Gene CEO, Richard Jagger presents at Pac 19th Australasian AgFood Conference
02-07-2021 Bio-Gene CEO, Richard Jagger, interviews Professor Catherine Hill (Highlights)
02-07-2021 Bio-Gene CEO, Richard Jagger, interviews Professor Catherine Hill (Full Interview)
24-06-2021 Bio-Gene CEO, Richard Jagger, interviews Doug Rathbone
10-06-2021 Bio-Gene CEO, Richard Jagger speaks to AusBiz TV
13-05-2021 Bio-Gene Company Briefing
13-05-2021 Bio-Gene Corporate Presentation
15-04-2021 Monsoon Twilight Investor Briefing Presentation
23-04-2020 Video Presentation on Public Health Mosquito Partnership
23-04-2020 Presentation on Public Health Mosquito Partnership
13-12-2019 Presentation on Breakthrough in Control of Resistant Mosquitoes
12-12-2019 Bio-Gene Investor Call
05-12-2019 Bio-Gene CEO, Richard Jagger speaks to Finance News Network
28-11-2019 Bio-Gene CEO, Richard Jagger speaks with Pitt Street Research
26-11-2019 Bio-Gene 2019 AGM - CEO Presentation Video
23-09-2019 Richard Jagger speaks with Boardroom Media
23-09-2019 Bio-Gene Investor Call
23-09-2019 Commercial Strategy Update
04-09-2019 Richard Jagger speaks with Boardroom Media
27-03-2019 Bio-Gene Investor Call
20-11-2018 CEO Presentation at 2018 AGM
17-10-2018 Richard Jagger, Bio-Gene speaks with Proactive Investors Australia
15-10-2018 Bio-Gene Updated Company Presentation
29-06-2018 Bio-Gene CEO Richard Jagger discusses positive study results for Flavocide™ on bee safety
29-06-2018 Bio-Gene and Flavocide™ at Australian Grain Storage and Protection Conference
30-05-2018 BIO-GENE INVESTOR UPDATE
26-03-2018 BIO-GENE INVESTOR CALL
28-11-2017 BIO-GENE INVESTOR BRIEFING